Literature DB >> 7670778

Elevated serum nitrate concentrations in active spondyloarthropathies.

D O Stichtenoth1, J Wollenhaupt, D Andersone, H Zeidler, J C Frölich.   

Abstract

We determined the concentrations of nitrate, reflecting endogenous nitric oxide (NO) production, by gas chromatography in the sera of patients with spondyloarthropathy. In those patients with active disease, as indicated by elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) serum nitrate levels (n = 7; mean 73.2 +/- s.d. 21.7 mumol/l) were significantly (P < 0.001) increased in comparison to patients with inactive spondyloarthropathy (n = 7; 31.7 +/- 9.5 mumol/l) and healthy volunteers (n = 10; 33.4 +/- 15.9 mumol/l). The nitrate serum levels correlated closely with CRP and ESR (r = 0.8, P < 0.001, each). There were no major differences in dietary nitrate intake between the study groups. The increased concentrations of serum nitrate in patients with active spondyloarthropathy indicate that NO production is enhanced in these patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7670778     DOI: 10.1093/rheumatology/34.7.616

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  5 in total

1.  Animal models of the spondyloarthropathies.

Authors:  M Breban; G Falgarone; H Blanchard; E Dernis-Labous; D Lamarque
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

2.  The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis.

Authors:  Murat Karkucak; Erhan Capkin; Ahmet Alver; Ayse Akyuz; Abdulkadir Kiris; Emel Ak; Murat Topbas; Mehmet Tosun
Journal:  Clin Rheumatol       Date:  2009-12-11       Impact factor: 2.980

3.  Thiol/disulfide homeostasis in patients with ankylosing spondylitis.

Authors:  Atalay Dogru; Ayse Balkarli; Gozde Yildirim Cetin; Salim Neselioglu; Ozcan Erel; Sevket Ercan Tunc; Mehmet Sahin
Journal:  Bosn J Basic Med Sci       Date:  2016-05-16       Impact factor: 3.363

4.  Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis.

Authors:  Salih Ozgocmen; Sadik Sogut; Ozge Ardicoglu; Ersin Fadillioglu; Irfan Pekkutucu; Omer Akyol
Journal:  Rheumatol Int       Date:  2003-06-17       Impact factor: 2.631

5.  Serum oxidative-antioxidative status in patients with ankylosing spondilitis.

Authors:  Mehmet Karakoc; Ozlem Altindag; Huseyin Keles; Neslihan Soran; Sahabettin Selek
Journal:  Rheumatol Int       Date:  2007-04-19       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.